Intravitreal Injection of Erythropoietin Glycosylation Analogs Does Not Protect Rod Photoreceptor Cells from Light-Induced Damage

  • Masaki TanitoEmail author
  • Feng Li
  • Robert E. Anderson
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 723)


Previous studies have shown that systemic up-regulation of erythropoietin (Epo) protects retina from light-induced retinal degeneration. Aranesp (darbepoetin alfa) and AMG114, hyperglycosylated forms of Epo, are recently developed Epo-analogs with an extended circulating half-life in vivo. We tested the protective effect of intravitreal injection of Epo glycosylation analogs in a rat model of retinal degeneration. Albino rats were injected in one eye with 0.2, 2, 20 ng of Aranesp or AMG114, and in the other eye with carrier, and then exposed to bright light (2,700 lx for 6 h) 2 days after the injection. Seven days after the light exposure, electroretinograms (ERG) were recorded and eyes were removed to measure outer nuclear layer (ONL) thickness. The retinal protection due to local injury and systemic anesthesia related to the intravitreal injection procedure was observed at day 1, but was significantly decreased by day 2. The ERG b-wave amplitudes and ONL thickness were not significantly different between right and left eyes in any of experimental groups, indicating no retinal protection by the Epo-analogs functionally and structurally. Aranesp and AM114 delivered intravitreally do not protect rod photoreceptor cells from light-induced damage.


Retinal light damage Erythropoietin Outer nuclear layer thickness Electroretinogram 



The authors are grateful to Mark Dittmar (Dean A. McGee Eye Institute) for maintaining the animals used in this study and to Louisa J. Williams and Linda S. Boone (Dean A. McGee Eye Institute) for their excellent retinal section preparation. This study was supported by a contract from Amgen, Inc. (Thousand Oaks, CA) and grants from the National Eye Institute (EY04149, EY00871, and EY12190); National Center for Research Resources (RR17703); Research to Prevent Blindness, Inc.; and the Foundation Fighting Blindness.


  1. Arcasoy MO (2008) The non-haematopoietic biological effects of erythropoietin. Br J Haematol 141:14–31PubMedCrossRefGoogle Scholar
  2. Faktorovich EG, Steinberg RH, Yasumura D et al (1992) Basic fibroblast growth factor and local injury protect photoreceptors from light damage in the rat. J Neurosci 12:3554–3567PubMedGoogle Scholar
  3. Grimm C, Wenzel A, Groszer M et al (2002) HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 8:718–724PubMedCrossRefGoogle Scholar
  4. Grimm C, Wenzel A, Stanescu D et al (2004) Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci 24:5651–5658PubMedCrossRefGoogle Scholar
  5. Noell WK, Walker VS, Kang BS et al (1966) Retinal damage by light in rats. Invest Ophthalmol 5:450–473PubMedGoogle Scholar
  6. Ranchon Cole I, Bonhomme B, Doly M (2007) Pre-treatment of adult rats with high doses of erythropoietin induces caspase-9 but prevents light-induced retinal injury. Exp Eye Res 85:782–789PubMedCrossRefGoogle Scholar
  7. Rex TS, Allocca M, Domenici L et al (2004) Systemic but not intraocular Epo gene transfer ­protects the retina from light-and genetic-induced degeneration. Mol Ther 10:855–861PubMedCrossRefGoogle Scholar
  8. Sinclair AM, Coxon A, McCaffery I et al (2010) Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells. Blood 115:4264–4272PubMedCrossRefGoogle Scholar
  9. Swift S, Ellison AR, Kassner P et al (2010) Absence of functional EpoR expression in human tumor cell lines. Blood 115:4254–4263PubMedCrossRefGoogle Scholar
  10. Tanito M, Kaidzu S, Ohira A et al (2008) Topography of retinal damage in light-exposed albino rats. Exp Eye Res 87:292–295PubMedCrossRefGoogle Scholar
  11. Tanito M, Li F, Elliott MH et al (2007) Protective effect of TEMPOL derivatives against light-induced retinal damage in rats. Invest Ophthalmol Vis Sci 48:1900–1905PubMedCrossRefGoogle Scholar
  12. Wen R, Song Y, Cheng T et al (1995) Injury-induced upregulation of bFGF and CNTF mRNAS in the rat retina. J Neurosci 15:7377–7385PubMedGoogle Scholar
  13. Wenzel A, Grimm C, Samardzija M et al (2005) Molecular mechanisms of light-induced ­photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Retin Eye Res 24:275–306PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Masaki Tanito
    • 1
    • 2
    • 3
    Email author
  • Feng Li
    • 1
    • 2
  • Robert E. Anderson
    • 1
    • 2
    • 4
  1. 1.Department of OphthalmologyUniversity of Oklahoma Health Sciences CenterOklahoma CityUSA
  2. 2.Dean A. McGee Eye InstituteOklahoma CityUSA
  3. 3.Department of OphthalmologyShimane University Faculty of MedicineIzumoJapan
  4. 4.Department of Cell BiologyUniversity of Oklahoma Health Sciences CenterOklahoma CityUSA

Personalised recommendations